Learning Objectives:
1. Describe different subtypes of diffuse midline gliomas
2. Describe how the cell-of-origin may impact tumorigenesis
3. Describe how preclinical models can help guide future clinical trials.
Session date:
11/29/2023 - 7:30am to 8:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Oren J Becher, MD